Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products, with an emphasis on life science-based innovation and production excellence. Emerald’s three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities.

Recent News

  • Emerald Health Therapeutics Licenses New Proprietary Cannabis Dried Flower Format Patent for use in United States

    Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered into a license agreement (the "Agreement") with FlowerPod LLC ("FP"), a private US company, providing FP with the exclusive use of certain Emerald patented technology for developing and marketing cannabis related products for use in all US states and other key geographies where adult use and/or medical cannabis is legal.The initial prototype product designed by Emerald, utilizing its Defined Dose™...

    2021-05-06 7:00 AM EDT
  • Emerald Health Therapeutics Appoints Moe Jiwan as Chief Operating Officer

    Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed Mr. Moe Jiwan as Chief Operating Officer effective May 10th.Mr. Jiwan is a data-driven business leader with over 20 years of diverse experience in strategic development, sales and operations management, e-commerce, and developing data and business intelligence solutions. Before joining Emerald, he served in senior leadership positions, including chief information officer and chief customer officer, for established cannabis and health companies,...

    2021-05-04 7:00 AM EDT
  • Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update

    Vancouver, British Columbia--(Newsfile Corp. - May 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released its financial results for the 12 months ended December 31, 2020. Full versions of Emerald's audited consolidated financial statements and management discussion and analysis were filed on SEDAR today at 7:00 ET and will be available at www.sedar.com."We ended 2020 with a complete transformation of Emerald's balance sheet and operating overhead, and strong positioning with respect to our strategic plan...

    2021-05-03 7:10 AM EDT
  • Emerald Health Therapeutics Confirms Effective Listing Date on Canadian Securities Exchange

    Vancouver, British Columbia--(Newsfile Corp. - April 23, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald" or "the Company") has received final approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"). The Company will voluntarily delist its Common Shares from the TSX Venture Exchange (the "TSXV") after market close on Monday, April 26, 2021. The Common Shares will commence trading on the CSE under the same symbol, EMH, at market open...

    2021-04-23 7:00 AM EDT
  • Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis

    Vancouver, British Columbia--(Newsfile Corp. - March 17, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has formed a partnership with Medical Plants SLU, based in Almeria, Spain, in which it will provide resources and expertise to assist Medical Plants to produce medical cannabis dried flower and 2.0 products to serve emerging legal medical cannabis markets in the EU and other countries that require high-grade GMP-certified flower or derivatives. Medical Plants is a wholly-owned subsidiary of Cualin...

    2021-03-17 7:00 AM EDT
  • Emerald Health Therapeutics Announces Intention to List on Canadian Securities Exchange

    Vancouver, British Columbia--(Newsfile Corp. - March 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has applied to the Canadian Securities Exchange ("CSE") to have its common shares listed for trading on the CSE. In connection with the listing of its common shares on the CSE, Emerald will apply to the TSX Venture Exchange ("TSXV") to have its common shares delisted from trading on the TSXV.Listing its common shares on the CSE will...

    2021-03-09 7:00 AM EST
  • Emerald Health Therapeutics to Close Greater Vancouver Production Facility

    Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will cease operations at its cannabis production facility in Greater Vancouver, British Columbia effective March 31, 2021 and will consider strategic alternatives for this facility. "Closing our Greater Vancouver production facility is part of Emerald's revised business strategy and transition away from the value segment of the cannabis market toward science-driven product development and the defined-scale production of...

    2021-02-18 4:45 PM EST
  • Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans

    Vancouver, British Columbia--(Newsfile Corp. - February 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received from Village Farms International Inc. $19.9M plus $621,534.25 in interest, representing full repayment of the promissory note issued by Village Farms to Emerald as part of its purchase of Emerald's interest in the Pure Sunfarms joint venture which closed in November 2020. This was the final payment due as part of this transaction. "After previously eliminating all third-party debt, and...

    2021-02-09 7:00 AM EST